NB-UVB phototherapy may restore adalimumab efficacy in chronic plaque psoriasis after treatment failure. Learn more about ...

Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...

The results position Takeda, which acquired its therapy in one of the industry’s larger single-drug acquisitions, to challenge Bristol Myers Squibb’s Sotyktu.

Psoriasis is a lifelong condition that comes and goes in flares, and the key to managing it is the right treatment. Your dermatologist will help you find a therapy based on: How bad your symptoms are ...

The treatment of psoriasis—an autoimmune disease that creates red, scaly plaques on the skin—depends on multiple factors, but two big factors include the severity and the location of the symptoms, ...

A large US claims analysis links out-of-pocket medication costs with adherence and discontinuation patterns among patients ...

Oregon Medical Research Center in Portland, Oregon, has led a phase 2 trial in moderate-to-severe plaque psoriasis that ...

The clinical-stage biotechnology company is seeking regulatory clearance to begin clinical trials of CYPS317, an allogeneic ...

Adjunctive narrowband ultraviolet B (NB-UVB) phototherapy may help restore clinical response in patients with chronic plaque psoriasis who develop secondary failure to adalimumab, according to a small ...

The following medications are indicated for plaque psoriasis, unless otherwise specified. Impoyz 0.025% crm Adults: Apply twice daily; max 50g/week and 2 consecutive weeks’ treatment per course.

Itchy, flaky psoriasis is never fun, but it can also sometimes be downright painful. Working with your derm to find the right treatment option is crucial, but with so many potential options to choose ...

Search online for psoriasis images, and you'll mostly find photos of white people. But that doesn’t reflect the reality of this skin condition. People with dark skin get psoriasis, too. Fewer African ...